Cambiar Investors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.4M Buy
228,271
+56,748
+33% +$15.7M 2.19% 13
2026
Q1
$50.7M Sell
171,523
-34,788
-17% -$10.3M 2.35% 12
2025
Q4
$56.3M Buy
206,311
+57,411
+39% +$15.6M 2.52% 5
2025
Q3
$40.2M Sell
148,900
-12,311
-8% -$3.35M 1.83% 27
2025
Q2
$44.4M Sell
161,211
-98,827
-38% -$26.9M 1.87% 21
2025
Q1
$69M Sell
260,038
-9,589
-4% -$2.37M 2.92% 2
2024
Q4
$62.6M Sell
269,627
-15,075
-5% -$3.47M 2.48% 4
2024
Q3
$62.8M Sell
284,702
-3,433
-1% -$710K 2.42% 3
2024
Q2
$56.6M Buy
288,135
+85,548
+42% +$17.7M 2.22% 8
2024
Q1
$43.6M Buy
202,587
+65,744
+48% +$13.8M 1.62% 24
2023
Q4
$28.8M Sell
136,843
-21,767
-14% -$4.64M 1.14% 38
2023
Q3
$31.8M Buy
158,610
+19,811
+14% +$3.94M 1.35% 30
2023
Q2
$25.7M Buy
+138,799
New +$25.7M 1.09% 39

Other funds holding CME

Cambiar Investors's CME Position: Q2 2026 in Review

Cambiar Investors increased its CME Group (CME) stake by 33% in Q2 2026, buying an estimated $15.7M and bringing the position to 228,271 shares worth $50.4M. The position accounts for 2.19% of the portfolio, ranked #13.

Cambiar Investors first reported a position in CME in Q2 2023 and has held it in 13 quarters since. The position peaked at $69M in Q1 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Cambiar Investors held 228,271 shares of CME Group worth $50.4M as of Q2 2026.
  • Cambiar Investors bought 56,748 CME Group shares in Q2 2026, an estimated $15.7M.
  • CME Group made up 2.19% of Cambiar Investors's portfolio in Q2 2026, its #13 holding.
  • Cambiar Investors first reported a position in CME Group in Q2 2023 and has held it in 13 quarters since.
  • Cambiar Investors's CME Group position peaked at $69M in Q1 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.